Skip to main content
Clinical Trials/NCT06657092
NCT06657092
Completed
Not Applicable

Ultrasound Guided Erector Spinae Plane Efficacy of Erector Spinae Plane Block for Analgesia in Breast Surgery

Gözde Gamze Uzun1 site in 1 country42 target enrollmentMarch 4, 2020
ConditionsBreast Diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Diseases
Sponsor
Gözde Gamze Uzun
Enrollment
42
Locations
1
Primary Endpoint
Total opioid consumption
Status
Completed
Last Updated
last year

Overview

Brief Summary

Patients were randomized into two groups, ESP and control. Single-shot ultrasound (US)-guided ESP block with 20 ml 0.25% bupivacaine at the T4 vertebral level was performed preoperatively to all patients in the ESP group. The control group received no intervention. Patients in both groups were provided with intravenous patient-controlled analgesia device containing morphine for postoperative analgesia.

Registry
clinicaltrials.gov
Start Date
March 4, 2020
End Date
December 30, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Gözde Gamze Uzun
Responsible Party
Sponsor Investigator
Principal Investigator

Gözde Gamze Uzun

Consultant Anesthesiologist

Kocaeli University

Eligibility Criteria

Inclusion Criteria

  • Patients who scheduled for bilateral reduction mammoplasty
  • ASA Class I-II

Exclusion Criteria

  • Coagulopaty

Outcomes

Primary Outcomes

Total opioid consumption

Time Frame: Postoperative total opioid consumption in miligrams will be recorded at hour 24

Patients in both groups will receive opioid in postoperative period. Total opioid consumption in miligrams will be compared

Secondary Outcomes

  • Intraoperative opioid consumption(At the end of the operation)

Study Sites (1)

Loading locations...

Similar Trials